Protocol Ledger

NCT07159841 · Phase II/III · RECRUITING

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

Interventional Phase II/III clinical trial protocol NCT07159841 sponsored by Crinetics Pharmaceuticals in Gastroenterology, Hepatology, and Renal, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-01-22 Enrollment: 153 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07159841
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)153 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07159841
Protocol FieldVerified Registry Value
NCT IdentifierNCT07159841
Consolidated Lead SponsorCrinetics Pharmaceuticals
Therapeutic Condition CohortGastroenterology, Hepatology, and Renal
Clinical Trial PhasePhase II/III
Overall Recruitment StatusRECRUITING
Registered Enrollment153 participants (ESTIMATED)
Registered Start Date2026-01-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI